Short Report

Does Lymphocyte / CRP Ratio Predict Progression of Disease in Covid-19 Patients With Myocardial Injury?

Volume: 3 Number: Supplement 1 March 7, 2021
EN

Does Lymphocyte / CRP Ratio Predict Progression of Disease in Covid-19 Patients With Myocardial Injury?

Abstract

Background: This study aims to reveal whether the Lymphocyte-C-reactive protein ratio (LCR), a systemic inflammatory marker, predicts disease progression in COVID-19 patients with myocardial injury. Methods: A total of 172 patients,18 years and older, hospitalized due to COVID 19 between April 2020 and May 2020 in our hospital were included retrospectively. Hg, leukocyte, lymphocyte, neutrophil, thrombocyte, AST, ALT, creatinine, LDH, albumin, ferritin, triglyceride, procalcitonin, C-reactive protein, fibrinogen, D-dimer, troponin, LCR values of the patients were recorded. LRC ratios were amplified as x100. Patients were divided into two groups as with and without myocardial injury. IBM SPSS Statistics 21.0 program was used for statistical analysis. Statistically, p <0.05 was considered significant. Results: Study patients were divided into two groups as with and without myocardial injury. The patients' mean age was 68.56 ± 13.43 years, 58.46 ± 16.67 years, respectively (p = 0.002). There was no difference between the groups in terms of the clinical severity of the disease, the severity of lung involvement on computed tomography, coronary artery disease, diabetes mellitus, chronic obstructive pulmonary disease, those with lymphocyte, CRP, LCR ratio, Ferritin, D-Dimer, and fibrinogen (all p> 0.05). Hypertension (HT), chronic renal failure (CRF) were more common in the group with myocardial injury (p <0.01, p <0.01). Procalcitonin and creatine levels were significantly higher in the group with myocardial injury (p = 0.002, p <0.001). When we analyzed the correlation analysis of parameters associated with myocardial injury with troponin, it showed a good correlation with CRF (r = 484, p <0.001), moderate with procalcitonin (r = 274, p <0.001, and weak correlation with age and HT (r = 484, p <0.001) = 180, p = 018) (r = 159, p = 037),respectively. DM and D-dimer did not correlate (r = 055, p = 472) (r = 072 p = 345).In the multivariate regression analysis, only CRF (Odds ratio (OD): 11.062 (95% confidence interval (CI): 1.866-65.580)) and reference procalcitonin levels (OR: 1.183, 95% CI: 1.014-1.379) predicted myocardial injury. Conclusion: Our study found that LRC did not predict disease progression in Covid-19 patients with myocardial injury.

Keywords

References

  1. Ghahramani, S., Tabrizi, R., Lankarani, K.B. et al. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis. Eur J Med Res 25, 30 (2020)

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Short Report

Publication Date

March 7, 2021

Submission Date

February 7, 2021

Acceptance Date

March 4, 2021

Published in Issue

Year 1970 Volume: 3 Number: Supplement 1

APA
Karabulut, U., & Karabulut, D. (2021). Does Lymphocyte / CRP Ratio Predict Progression of Disease in Covid-19 Patients With Myocardial Injury? Turkish Journal of Internal Medicine, 3(Supplement 1), 25-26. https://doi.org/10.46310/tjim.875857
AMA
1.Karabulut U, Karabulut D. Does Lymphocyte / CRP Ratio Predict Progression of Disease in Covid-19 Patients With Myocardial Injury? Turk J Int Med. 2021;3(Supplement 1):25-26. doi:10.46310/tjim.875857
Chicago
Karabulut, Umut, and Dilay Karabulut. 2021. “Does Lymphocyte CRP Ratio Predict Progression of Disease in Covid-19 Patients With Myocardial Injury?”. Turkish Journal of Internal Medicine 3 (Supplement 1): 25-26. https://doi.org/10.46310/tjim.875857.
EndNote
Karabulut U, Karabulut D (March 1, 2021) Does Lymphocyte / CRP Ratio Predict Progression of Disease in Covid-19 Patients With Myocardial Injury? Turkish Journal of Internal Medicine 3 Supplement 1 25–26.
IEEE
[1]U. Karabulut and D. Karabulut, “Does Lymphocyte / CRP Ratio Predict Progression of Disease in Covid-19 Patients With Myocardial Injury?”, Turk J Int Med, vol. 3, no. Supplement 1, pp. 25–26, Mar. 2021, doi: 10.46310/tjim.875857.
ISNAD
Karabulut, Umut - Karabulut, Dilay. “Does Lymphocyte CRP Ratio Predict Progression of Disease in Covid-19 Patients With Myocardial Injury?”. Turkish Journal of Internal Medicine 3/Supplement 1 (March 1, 2021): 25-26. https://doi.org/10.46310/tjim.875857.
JAMA
1.Karabulut U, Karabulut D. Does Lymphocyte / CRP Ratio Predict Progression of Disease in Covid-19 Patients With Myocardial Injury? Turk J Int Med. 2021;3:25–26.
MLA
Karabulut, Umut, and Dilay Karabulut. “Does Lymphocyte CRP Ratio Predict Progression of Disease in Covid-19 Patients With Myocardial Injury?”. Turkish Journal of Internal Medicine, vol. 3, no. Supplement 1, Mar. 2021, pp. 25-26, doi:10.46310/tjim.875857.
Vancouver
1.Umut Karabulut, Dilay Karabulut. Does Lymphocyte / CRP Ratio Predict Progression of Disease in Covid-19 Patients With Myocardial Injury? Turk J Int Med. 2021 Mar. 1;3(Supplement 1):25-6. doi:10.46310/tjim.875857

30994   34277 29166

 

Turkish Journal of Internal Medicine, hosted by DERGİPARK, is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

by-nc-nd.png